Bollettino
PS – we urge readers to peruse this James Surowiecki article about Big Pharma , and then compare it to the LI criticism of a former Surowiecki piece on big pharma. We reproduce our piece, all the way back from 2001, here. Has Surowiecki been sneaking glances at our humble blog? The suggestion that he makes – that smaller R&D firms represent the coming wave of research, while the Pharma dinosaurs should either learn to market efficiently or die in their own stupors, is exactly the point we were making about the way monopoly has practically driven efficiency out of the big Pharma culture. Here’s our humble little piece:
In the November 5th New Yorker there is a column by the astute but limited James Surowiecki, who makes the standard case against breaking the Bayer patent on Cipro. The case goes like this: to come up with an antibiotic takes years of R & D, and R & D costs beaucoup millions; so if in the end, the anti-biotic isn't a moneymaker, then R &a
“I’m so bored. I hate my life.” - Britney Spears
Das Langweilige ist interessant geworden, weil das Interessante angefangen hat langweilig zu werden. – Thomas Mann
"Never for money/always for love" - The Talking Heads